Novavax & Cadila open Indian vaccine facility
Cadila Pharmaceuticals and Novavax have completed construction of their joint venture vaccine manufacturing plant in Dholka, India.
Cadila Pharmaceuticals and Novavax have completed construction of their joint venture vaccine manufacturing plant in Dholka, India.
OptiNose is to take its nasal drug delivery device into Phase III using $48.5m (€40m) a private equity firm has agreed to invest in the business.
in-PharmaTechnologist presents its latest round up of movements in the sector, including appointments at Pfizer, Biocodex, Unigene, Pieris and Progenics.
Parabolic Drugs will enter India’s CRAMS sector with new dedicated manufacturing facilities designed to attract “global innovator companies” enabling its business to grow in regulated markets.
CRO Phlexglobal is setting up an office in California, US to give it the North American presence requested by clients.
Patheon has posted a 12 per cent growth in operating profit in the second quarter and said there is “strong evidence” the business environment is improving.